spacer
home > ebr > summer 2017 > protein productivity
PUBLICATIONS
European Biopharmaceutical Review

Protein Productivity

The marginal stability of proteins substantially complicates the safe and efficacious delivery of biopharmaceuticals, making the investigation and control of stability a primary focus throughout product development. Liquid – as opposed to lyophilised – formulations offer the significant clinical advantage of greater ease of administration and are generally the preferred option for delivering biologics. However, they are challenging from the perspective of stability.

Identifying the excipients and handling strategies that maximise the physical stability of a candidate molecule and minimise any chemical degradation is an essential task. Analytical tools that enable the confident assessment and prediction of stability are consequently of significant value to formulators, especially when they provide data that correlate well with the accelerated or long-term stability studies required ahead of regulatory approval.

There is widespread recognition within the industry that, when it comes to comprehensively understanding stability, no singular approach holds all the answers. Rather, an array of orthogonal techniques is needed. Selecting a suite of the most relevant and informative methods is crucial as stability investigations ramp up from pre-formulation onwards, but so too is understanding how to rationalise what can be extensive and non-converging datasets.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Lisa Newey-Keane is the Life Sciences Sector Marketing Manager for Malvern Instruments, based at the company’s head office in Britain. She holds a PhD in microbiology/ protein biochemistry from the University of Birmingham, UK, and her industry background is within contract manufacture and research, primarily for biopharmaceuticals and anti-infectives.
spacer
Lisa Newey-Keane
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement